KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $45.4 billion.

  • Novartis Ag's Retained Earnings rose 486.77% to $45.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $45.4 billion, marking a year-over-year increase of 486.77%. This contributed to the annual value of $45.4 billion for FY2025, which is 486.77% up from last year.
  • Per Novartis Ag's latest filing, its Retained Earnings stood at $45.4 billion for Q4 2025, which was up 486.77% from $43.6 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Retained Earnings ranged from a high of $66.8 billion in Q4 2021 and a low of $37.4 billion during Q3 2023
  • For the 5-year period, Novartis Ag's Retained Earnings averaged around $49.3 billion, with its median value being $47.8 billion (2021).
  • Its Retained Earnings has fluctuated over the past 5 years, first skyrocketed by 2220.46% in 2022, then tumbled by 3771.5% in 2023.
  • Quarter analysis of 5 years shows Novartis Ag's Retained Earnings stood at $66.8 billion in 2021, then fell by 12.36% to $58.5 billion in 2022, then decreased by 21.63% to $45.9 billion in 2023, then fell by 5.62% to $43.3 billion in 2024, then increased by 4.87% to $45.4 billion in 2025.
  • Its last three reported values are $45.4 billion in Q4 2025, $43.6 billion for Q3 2025, and $41.3 billion during Q2 2025.